[go: up one dir, main page]

DE60006799D1 - Oralverabreichbare lösung von prucaloprid - Google Patents

Oralverabreichbare lösung von prucaloprid

Info

Publication number
DE60006799D1
DE60006799D1 DE60006799T DE60006799T DE60006799D1 DE 60006799 D1 DE60006799 D1 DE 60006799D1 DE 60006799 T DE60006799 T DE 60006799T DE 60006799 T DE60006799 T DE 60006799T DE 60006799 D1 DE60006799 D1 DE 60006799D1
Authority
DE
Germany
Prior art keywords
prucaloprid
addable
oral
solution
addable solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60006799T
Other languages
English (en)
Other versions
DE60006799T2 (de
Inventor
Proost Eddy Andre Josee De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Movetis NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE60006799D1 publication Critical patent/DE60006799D1/de
Application granted granted Critical
Publication of DE60006799T2 publication Critical patent/DE60006799T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60006799T 1999-04-29 2000-04-20 Oralverabreichbare lösung von prucaloprid Expired - Lifetime DE60006799T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99201335 1999-04-29
EP99201335 1999-04-29
PCT/EP2000/003739 WO2000066170A1 (en) 1999-04-29 2000-04-20 Prucalopride oral solution

Publications (2)

Publication Number Publication Date
DE60006799D1 true DE60006799D1 (de) 2004-01-08
DE60006799T2 DE60006799T2 (de) 2004-09-23

Family

ID=8240160

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60006799T Expired - Lifetime DE60006799T2 (de) 1999-04-29 2000-04-20 Oralverabreichbare lösung von prucaloprid

Country Status (36)

Country Link
US (1) US6413988B1 (de)
EP (1) EP1176982B1 (de)
JP (1) JP4773619B2 (de)
KR (1) KR100669175B1 (de)
CN (1) CN1165345C (de)
AR (1) AR023815A1 (de)
AT (1) ATE254929T1 (de)
AU (1) AU770073B2 (de)
BG (1) BG65061B1 (de)
BR (1) BRPI0010150B8 (de)
CA (1) CA2371178C (de)
CZ (1) CZ294070B6 (de)
DE (1) DE60006799T2 (de)
DK (1) DK1176982T3 (de)
EA (1) EA003904B1 (de)
EE (1) EE05264B1 (de)
ES (1) ES2211546T3 (de)
HK (1) HK1045950B (de)
HR (1) HRP20010764B1 (de)
HU (1) HU228924B1 (de)
ID (1) ID30397A (de)
IL (2) IL146152A0 (de)
JO (1) JO2181B1 (de)
MX (1) MXPA01010953A (de)
MY (1) MY119880A (de)
NO (1) NO331448B1 (de)
NZ (1) NZ515119A (de)
PL (1) PL195674B1 (de)
PT (1) PT1176982E (de)
SI (1) SI1176982T1 (de)
SK (1) SK284847B6 (de)
TR (1) TR200103121T2 (de)
TW (1) TW592709B (de)
UA (1) UA68426C2 (de)
WO (1) WO2000066170A1 (de)
ZA (1) ZA200108820B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050063998A1 (en) * 1999-10-26 2005-03-24 Francois Marc Karel Jozef Oral solution containing galantamine and a sweetening agent
WO2002041918A2 (en) * 2000-11-24 2002-05-30 Janssen Pharmaceutica N.V. Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage
US20050085510A1 (en) * 2002-01-16 2005-04-21 Telefonaktiebolaget Lm Ericsson (Publ) Prucalopride-n-oxide
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
EP1789067B8 (de) 2004-08-12 2012-08-15 Helsinn Healthcare S.A. Verwendung von Wachstumshormon-sekretagoga zur Stimulierung der Motilität des gastrointestinalen Systems
GB201103397D0 (de) * 2011-02-28 2011-04-13 Shire Movetis N V
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations
CN119700664B (zh) * 2025-02-28 2025-06-20 山东新时代药业有限公司 含有活性成分琥珀酸普芦卡必利的注射液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JPH05163154A (ja) * 1991-12-13 1993-06-29 Kanebo Ltd 経口液剤
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
CA2352278A1 (en) * 1998-11-23 2000-06-02 Janssen Pharmaceutica, N.V. Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia

Also Published As

Publication number Publication date
IL146152A0 (en) 2002-07-25
NO20014794D0 (no) 2001-10-02
CA2371178C (en) 2008-03-25
TR200103121T2 (tr) 2002-05-21
TW592709B (en) 2004-06-21
BRPI0010150B8 (pt) 2021-05-25
PT1176982E (pt) 2004-04-30
DK1176982T3 (da) 2004-03-29
BG65061B1 (bg) 2007-01-31
HK1045950A1 (en) 2002-12-20
EA003904B1 (ru) 2003-10-30
NO331448B1 (no) 2012-01-02
HRP20010764A2 (en) 2002-12-31
MXPA01010953A (es) 2002-05-06
CZ294070B6 (cs) 2004-09-15
SK15192001A3 (sk) 2002-03-05
US6413988B1 (en) 2002-07-02
HRP20010764B1 (hr) 2011-01-31
PL352062A1 (en) 2003-07-28
CA2371178A1 (en) 2000-11-09
AR023815A1 (es) 2002-09-04
HU228924B1 (en) 2013-06-28
ES2211546T3 (es) 2004-07-16
EE05264B1 (et) 2010-02-15
EP1176982A1 (de) 2002-02-06
HUP0202324A2 (hu) 2002-12-28
UA68426C2 (uk) 2004-08-16
BR0010150A (pt) 2002-01-15
CN1165345C (zh) 2004-09-08
EP1176982B1 (de) 2003-11-26
CZ20013735A3 (cs) 2002-02-13
PL195674B1 (pl) 2007-10-31
NZ515119A (en) 2003-05-30
AU770073B2 (en) 2004-02-12
KR20020004972A (ko) 2002-01-16
NO20014794L (no) 2001-10-02
HUP0202324A3 (en) 2003-03-28
JP4773619B2 (ja) 2011-09-14
EA200101150A1 (ru) 2002-04-25
WO2000066170A1 (en) 2000-11-09
JP2002543161A (ja) 2002-12-17
MY119880A (en) 2005-07-29
SI1176982T1 (en) 2004-04-30
HK1045950B (zh) 2005-05-27
KR100669175B1 (ko) 2007-01-17
SK284847B6 (sk) 2006-01-05
BG106031A (en) 2002-05-31
AU4913700A (en) 2000-11-17
ZA200108820B (en) 2003-01-27
IL146152A (en) 2006-12-31
ID30397A (id) 2001-11-29
EE200100539A (et) 2002-12-16
BRPI0010150B1 (pt) 2015-06-23
CN1348386A (zh) 2002-05-08
JO2181B1 (en) 2003-04-23
ATE254929T1 (de) 2003-12-15
DE60006799T2 (de) 2004-09-23

Similar Documents

Publication Publication Date Title
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
EP1073466A4 (de) Nikotin enthaltende lösung
DE69941116D1 (de) G von gdf-8
ATE239011T1 (de) Neuartige form von s-omeprazol
DE69837906D1 (de) Insektizides proteintoxin von xenorhabus
DE60136181D1 (de) 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
DE69932273D1 (de) Befestigung von Biomolekülen an Oberflächen von medizinischen Geräten
DK1062480T3 (da) Gyroskop
EP1223879A4 (de) Kauterisation von gewebe mit ausfahrbaren elektroden
DE60033896D1 (de) Unterscheidung von Modulationsarten
EP1294513A4 (de) Lokalisationsspezifische kovalente biokonjugation von proteinen
DE69907146T2 (de) Direkte oxidation von cycloalkanen
DE60019960D1 (de) Herstellung von isobutencopolymere
DE69839679D1 (de) Handlung von verschiedenen protokollen
ATE315937T1 (de) Pharmazeutische lösung von levosimendan
DE69801676D1 (de) Wässrige emulsionen von fischer-tropschparaffinen
DE50003755D1 (de) Satz von schmuckstücken
DE69806558D1 (de) Stabilisierung von 3-Isothiazolonlösungen
DE60006799D1 (de) Oralverabreichbare lösung von prucaloprid
DK1064519T3 (da) Toakset gyroskop
DE60000343D1 (de) Stabilisierung von isothiazolonen
DE69941094D1 (de) Stossverbinden von gummibahnen
DE60026931D1 (de) Ausrichtung von Ausdrucken
DE69927626D1 (de) Ausführung von Permutationen
DE60022125D1 (de) Tiefstkühlen von Waren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MOVETIS N.V., TURNHOUT, BE